The role of liquid biopsy in the management of concurrent Hodgkin lymphoma and ovarian carcinoma treated with nivolumab
{{output}}
The simultaneous occurrence of Hodgkin lymphoma (HL) and ovarian carcinoma (OC) is rare and presents unique challenges in diagnosis and treatment. Circulating tumour DNA (ctDNA) offers a minimally invasive method for detecting minimal residual disease in both ... ...
